A lawsuit to the United States Supreme Court is being brought by two pregnant people in Rhode Island, on behalf of their unborn children. Will it be considered? The pliaintiffs wish the Court to define personhood. Personhood is an opinion: that a fetus, embryo or blastocyst (fertilized human egg) must be treated as a person with full rights and protections under law. Briefly, the plaintiffs (below) applied to the Rhode Island Supreme Court and were denied, apparently on the basis of Roe v
Dublin, Oct. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Market, By Use Type, By Therapy Type, By Product, By Technology & By Region- Forecast and Analysis 2022-2028" report has been added to ResearchAndMarkets.com's offering. The Global Cell Therapy Market was valued at USD 14.86 Billion in 2021, and it is expected to reach a value of USD 35.95 Billion by 2028, at a CAGR of 13.45% over the forecast period (2022 - 2028). The cell therapy industry is being propelled forward by an increase in the number of clinical trials for cell-based treatments
Aileron Therapeutics, Inc. New ex vivo data demonstrates protection against cyclophosphamide-induced damage to hair follicles and their stem cells Encore presentation of data presented at Society for Investigative Dermatology in May 2022 shows: ALRN-6924 temporarily arrested the cell cycle in human scalp hair follicles and their stem cells Ex vivo data demonstrated protection against taxane-induced damage to hair follicles and their stem cells Nearly all breast cancer patients receiving neoadjuvant or adjuvant chemotherapy, including cyclophosphamide and taxanes, such as docetaxel, experience alopecia (hair loss) Aileron is evaluating ALRN-6924 as a novel chemoprotective agent to prevent chemotherapy-induced bone marrow toxicities and alopecia in its ongoing Phase 1b breast cancer trial BOSTON, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients lives, today announced an oral presentation at the European Society for Dermatological Research (ESDR) Annual Meeting, taking place September 28 October 1, 2022 in Amsterdam. This presentation includes non-clinical data initially presented at the Society for Investigative Dermatology in May 2022 as well as new non-clinical data developed in collaboration with Professor Ralf Paus, M.D., DSc, FRSB and his colleagues at the Dr.
The iconic countdown clock appears in the foreground, while the Falcon 9 rocket and Dragon spacecraft are seen in the background at NASAs Kennedy Space Center on Wednesday, Oct. 5, 2022. The mission is set to lift off today at noon EDT from the Florida spaceport. Credit: NASA Crew-5 astronauts will conduct new scientific research, including cardiac experiments to prepare for human exploration beyond low-Earth orbit and benefit life on Earth.
Dublin, Oct. 05, 2022 (GLOBE NEWSWIRE) -- The "Cell Isolation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global cell isolation market size reached US$ 10.3 Billion in 2021.
ReportLinker Global Cell And Gene Therapy Market 2022-2026 The analyst has been monitoring the cell and gene therapy market and it is poised to grow by $9. 97 bn during 2022-2026, accelerating at a CAGR of 20. New York, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cell and Gene Therapy Market 2022-2026" - https://www.reportlinker.com/p06325351/?utm_source=GNW 15% during the forecast period
Melhem Solh, MD, discusses his research on post-transplant outcomes of patients with TP53-mutant acute myeloid leukemia and myelodysplastic syndrome. Melhem Solh, MD, medical director for the Cellular Therapy Program at Northside Hospital, discusses his research on post-transplant outcomes of patients with TP53-mutant acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Investigators, including Solh, examined 30 patients to evaluate overall survival (OS), relapse and non-relapse mortality, and disease-free survival (DFS) in patients with AML or MDS with a TP53 mutation and who had underwent an allogeneic hematopoietic stem cell transplant for this indication.
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. Calgary, Alberta--(Newsfile Corp. - September 27, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce the appointment of Dr.
MELBOURNE, AUSTRALIA - 27 September 2022:Seven medical researchers have been awarded a CSL Research Acceleration Initiative (RAI) partnership, including up to an AU$500,000 investment in each program over two years, to fast-track the discovery of innovative biotherapies to address unmet medical needs. The CSL Research Acceleration Initiative establishes partnerships between CSL and global research organisations to accelerate commercialisation of promising discovery programs. In addition to creating long-term mutual partnerships to further innovation, the initiative includes funding as well as access to CSL R&D experts. The seven Global RAI awardees, selected via the 2021 call for proposals, include researchers from: The University of Queensland, University of Newcastle and ANZAC Research Institute in Australia; University of Pennsylvania in the US; Justus Liebig University Giessen and University Hospital of Ludwig Maximilian University of Munich in Germany; and University of Basel in Switzerland.
Los Angeles, USA: A recent report published by Verified Market Research, titled [Global Stem Cell Assay Market, History and Forecasts for 2022-2029, data broken down by manufacturers, key regions, types and applications], contains an in-depth analysis of the Global Stem Cell Assay Market. The research report is divided in such a way as to highlight the key areas of the market and give the reader a complete picture. The report examines various aspects of the Stem Cell Assay market, such as its opportunities to explore its driving forces and limitations, market size, market segment analysis, regional prospects, key players and the competitive environment. Market Research Report Stem Cell Assay uses the methodology of primary and secondary research to provide accurate data to its readers
Recent Comments